Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06777459

Study of Nitrate-Rich Juice on Cognitive Function in Heavy Alcohol Drinkers: a Two-Stage Adaptive Design Real-World Clinical Trial

It is known that alcohol consumption can lead to cognitive impairment and dysregulation of inflammatory responses. A preliminary randomized controlled trial conducted by our research team has suggested that nitrate may improve cognition in hospitalized patients with alcohol dependence. To further expand the population and applicability, this study aims to explore the effects of nitrate on cognition in a real-world population of heavy drinkers. The researchers have designed a two-stage clinical trial: the first stage involves the analysis of existing data, and the second stage will recruit 43-54 new participants for a 14-day dietary inorganic nitrate (nitrate-rich beetroot juice, ~750 mg NO3- /d) intervention.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Heavy Drinking

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

No comments

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

A. Individuals with a history of heavy alcohol consumption (as defined below), who have continued heavy drinking within the past week and have no plans to quit drinking within the next month.

B. Individuals with a history of heavy alcohol consumption who are currently hospitalized due to alcohol dependence or alcohol use disorder, and are still undergoing treatment.

The CDC (Centers for Disease Control and Prevention) defines heavy alcohol consumption as follows: For males: more than 15 standard alcoholic drinks per week. For females: more than 8 standard alcoholic drinks per week. Here, one standard drink unit is approximately 14 grams of pure alcohol- C. A Montreal Cognitive Assessment (MoCA) score greater than 13.

Exclusion criteria

A. Individuals with a history of or current infectious diseases. B. Individuals with a history of or current severe cardiovascular, cerebrovascular, hepatic, or renal diseases.

C. Individuals who are allergic to any substances used in the trial, such as beets.

Treatment and study plan

Nitrate-rich beetroot Juice

Dietary Supplement

Nitrate-rich beetroot juice, ~750 mg NO3- /d

Primary outcomes

  1. The number of responders with a DMS-PCAD score improvement of 6 or more after intervention compared to baseline

    Time frame: baseline and post-intervention(two weeks after baseline test)

    Test by DMS-PCAD (Delayed Match to Sample Percent Correct , all delays) The score range is from 0% to 100%, with higher scores indicating better performance in visual memory and matching tasks.

Secondary outcomes

  1. Changes of Spatial Working Memory Between Errors from baseline to post-intervention

    Time frame: baseline and post-intervention(two weeks after baseline test)

    Test by SWM-BE (The Spatial Working Memory Between Errors ) The SWM-BE score range is primarily based on the number of errors, typically ranging from 0 to 10 errors. The higher the score, the fewer the errors, and the better the performance.

  2. Changes of cognitive function from baseline to post-intervention

    Time frame: baseline and post-intervention(two weeks after baseline test)

    Test by Cambridge Neuropsychological Test Automatic Battery，CANTAB

  3. Changes of oral microbiota from baseline to post-intervention

    Time frame: baseline and post-intervention(two weeks after baseline test)

    Saliva samples were used to test the composition of microbiota by 16S RNA sequencing.

  4. Changes of inflammatory factors levels in serum from baseline to post-intervention

    Time frame: baseline and post-intervention(two weeks after baseline test)

    We collected serum sampleWs were used to test the levels of inflammatory factors by Elisa

  5. depression

    Time frame: baseline and post-intervention (two weeks after baseline test)

    Test by Self-Rating Depression Scale

  6. anxiety

    Time frame: baseline and post-intervention(two weeks after baseline test)

    Test by Self-Rating Anxiety Scale

  7. Sleep Quality

    Time frame: baseline and post-intervention (two weeks after baseline test)

    Test by pittsburgh sleep quality index

  8. Cognitive

    Time frame: baseline and post-intervention (two weeks after baseline test)

    Test by Montreal Cognitive Assessment

  9. Dream

    Time frame: baseline and post-intervention (two weeks after baseline test)

    Test by Dream Evaluation Scale

Study contacts

Contact information is provided by the study sponsor or research team.

FUYU Song

CONTACT

[email protected]

+8613699266767

Sponsors and collaborators

Lead sponsor

Peking University Sixth Hospital

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jan 15, 2025
Registry last updated
Jan 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.